StemCells (STEM) Receives $100K Grant from CIRM
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Down)Join SI Premium – FREE
StemCells, Inc. (Nasdaq: STEM), reports the California Institute of Regenerative Medicine (CIRM) has approved the Company's application for a "Disease Team Therapy Development Planning Award."
The grant, totaling approximately $100,000, will help fund the Company's plans to develop its proprietary human neural stem cell product, HuCNS-SC® cells, in Alzheimer's disease by enabling the Company and its collaborators at the University of California, Irvine, to prepare and submit an application for a "Disease Team Therapy Development Research Award."
The grant, totaling approximately $100,000, will help fund the Company's plans to develop its proprietary human neural stem cell product, HuCNS-SC® cells, in Alzheimer's disease by enabling the Company and its collaborators at the University of California, Irvine, to prepare and submit an application for a "Disease Team Therapy Development Research Award."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stem Announces First Quarter 2024 Earnings Results Conference Call
- Rocket Lab USA (RKLB) Announces Board Change
- Ocular Therapeutix (OCUL) Appoints Pravin U. Dugel as CEO
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
